ADVANCED SOLID TUMORS CANCER
Clinical trials for ADVANCED SOLID TUMORS CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ORB-021 enters human testing for advanced cancers
Disease control Recruiting nowThis early-phase study tests whether the investigational drug ORB-021 is safe and tolerable in 36 adults with advanced solid tumors that have not responded to standard treatments. Researchers will also find the best dose to use in future studies. Participants will go through scre…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New drug PQ203 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called PQ203 in people with advanced solid tumors, including triple-negative breast cancer. The main goals are to check the drug's safety and find the right dose for future studies. About 80 adults whose cancer has not responded to standard…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for hard-to-treat cancers: targeted combo therapy enters trials
Disease control Recruiting nowThis study tests a new drug (GFH375) combined with either cetuximab or chemotherapy in people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if the combination is safe and can shrink tumors. About 126 adults who have not responded to standa…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New daily pill aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, NDI-219216, in about 134 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and see if it can shrink tumors. Participants will take the pill daily, visit the …
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Live tumor biopsies could unlock secrets of immunotherapy success
Knowledge-focused Recruiting nowThis study collects tumor samples from 2,000 people with various cancers to learn how to predict who will respond to immunotherapy. Participants donate tissue during a routine biopsy. The goal is to understand tumor biology and improve future treatment decisions, not to test a ne…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated May 26, 2026 05:46 UTC